Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADDICTION RECOVERY MEDICAL SERVICES - PROVIDERS

NPI: 1669663175 · STATESVILLE, NC 28625 · Pain Medicine (Anesthesiology) Physician · NPI assigned 08/08/2007

$7.64M
Total Medicaid Paid
97,754
Total Claims
69,318
Beneficiaries
14
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKEARNEY, BOBBY (MD, MEDICAL DIRECTOR)
NPI Enumeration Date08/08/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 27,459 $2.08M
2019 28,331 $1.85M
2020 11,222 $791K
2021 9,424 $763K
2022 7,822 $760K
2023 7,411 $703K
2024 6,085 $692K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 24,099 19,526 $4.17M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 23,962 18,858 $1.74M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 16,095 10,214 $1.07M
99215 Prolong outpt/office vis 1,929 1,370 $200K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,512 909 $169K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 17,246 7,150 $139K
81025 9,087 8,707 $67K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,068 942 $56K
82075 2,469 1,427 $30K
99205 Prolong outpt/office vis 13 13 $2K
86580 58 57 $261.68
99406 22 22 $254.54
93000 14 13 $176.42
90832 Psychotherapy, 30 minutes with patient 180 110 $0.00